- Category
- Small (2023-24)
- Udyam number
- UDYAM-UP-28-0028373

About Iaso Pharmaceuticals Private Limited
Data last updated:
Iaso Pharmaceuticals Private Limited is a private limited company based in New Delhi, Delhi, India. It operates in the pharmaceutical retail and distribution segment of the pharmaceuticals sector. It was incorporated on 15 February 2011 and has been in existence for over 15 years.
The company is registered with the Registrar of Companies (ROC), Delhi, under CIN U24232DL2011PTC214139. Its GSTIN is 07AACCI5288D1ZK (Delhi). The company holds 3 GST registrations, of which 2 are active.
The company has an authorised share capital of ₹25 Lakh and a paid-up capital of ₹5 Lakh. It is led by directors Narender Kumar Chopra (Managing Director) and Keshav Chopra.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at G – 10 11 Ground Floor Vardhman Ac Market Vigyan Vihar, New Delhi, Delhi, India – 110092.
As per the financials filed for FY 2025, the company reported a revenue of ₹13.2 Cr, a growth of 4% compared to the previous year. For the same year it recorded a net profit of ₹3.43 Cr (net margin 26%) and EBITDA of ₹5.29 Cr (EBITDA margin 40.1%). Revenue has grown at a compounded annual rate (CAGR) of 1% over three years and 6% over five years.
Court records list 1 case involving the company, including 1 filed against it.
Iaso Pharmaceuticals Private Limited is registered as a small enterprise under the Udyam registration framework (Reg. No. UDYAM-UP-28-0028373). The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website iasopharmaceuticals.com.
Company details
Recognitions & Rankings of Iaso Pharmaceuticals
Contact details
Iaso Pharmaceuticals Private Limited's registered office is in New Delhi, Delhi. Its website is iasopharmaceuticals.com. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Website
- Registered AddressG – 10 11 Ground Floor Vardhman Ac Market Vigyan Vihar, New Delhi, Delhi, India – 110092
- IndustryPharma, Pharmaceutical Retailers & Distributors
To see the full contact details of Iaso Pharmaceuticals Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Iaso Pharmaceuticals is trade. In detail, this covers wholesale trading.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading |
To see the full business activity and turnover split of Iaso Pharmaceuticals Private Limited, buy the company report.
Financials of Iaso Pharmaceuticals Private Limited
FY 2025 filings availableIaso Pharmaceuticals Private Limited reported revenue of ₹13.2 Cr (up 4% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR)
Revenue has grown at a compounded annual rate (CAGR) of 6% over five years, including 4% growth in the latest year. EBITDA fell 1% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹5.29 Cr | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹3.43 Cr | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 40.1% | ||||
| Net Profit Margin | 26% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Iaso Pharmaceuticals Private Limited, buy the company report.
Board of directors of Iaso Pharmaceuticals Private Limited
Iaso Pharmaceuticals has 2 directors on record. No former directors are listed.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Narender Kumar Chopra Also directs: Splits and Cuts LLP, Icch Global Consulting Private Limited, Laureate Schools Private Limited and 2 more | Managing Director | 15 Feb 2011 | 15 Years 9 Months | Current |
| Keshav Chopra | Director | 15 Feb 2011 | 15 Years 9 Months | Current |
Auditor
Iaso Pharmaceuticals Private Limited is audited by PARVEEN GOYAL & CO for the financial year 2023.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| PARVEEN GOYAL & CO | FY 2023 | 029453N |
Shareholding
The shareholding of Iaso Pharmaceuticals Private Limited is on record for 5 financial years, the latest being FY 2023, split between promoters, domestic institutions, public shareholders and others.
| Shareholder category | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|---|
| Promoters | |||||
| Domestic institutional investors (DII) | |||||
| Public | |||||
| Others |
To see the full shareholding pattern of Iaso Pharmaceuticals Private Limited, buy the company report.
Legal cases
Iaso Pharmaceuticals Private Limited has 1 court case on record: 1 filed against it. All case is disposed.
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| District courts | 1 | 1 | 0 |
Cases on record (1 of 1)
| Court | Type of case | Party | Status |
|---|---|---|---|
| District court, Gautam Buddha Nagar, Uttar Pradesh | Criminal case | Filed against the company by State Government | Disposed |
To see the full case history of Iaso Pharmaceuticals Private Limited, buy the company report.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Iaso Pharmaceuticals Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Iaso Pharmaceuticals has 3 GST registrations: 2 active and 1 cancelled or inactive.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 07AACCI5288D1ZK | Delhi | Active | 01 Jul 2017 |
| 09AACCI5288D1ZG | Uttar Pradesh | Active | 11 May 2022 |
To see the full GST registrations and return filing status of Iaso Pharmaceuticals Private Limited, buy the company report.
Recent activity
Iaso Pharmaceuticals Private Limited has 2 board changes on record since 2011: 2 appointments. The latest: Keshav Chopra was appointed as Director on 15 Feb 2011.
Frequently asked questions
Iaso Pharmaceuticals is an active private limited company based in New Delhi, Delhi, India. The company works in pharmaceutical retailers and distributors, within the pharma industry. It was incorporated on 15 February 2011 (15+ years old) and is registered under CIN U24232DL2011PTC214139.
Iaso Pharmaceuticals has 2 current directors:
- Narender Kumar Chopra - Managing Director
- Keshav Chopra - Director
The latest financial statements of Iaso Pharmaceuticals on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from 2015 are in the company report.
The GSTIN of Iaso Pharmaceuticals is 07AACCI5288D1ZK, registered in Delhi. The company has 3 GST registrations in all, of which 2 are active and 1 is cancelled or inactive. Other active GSTINs include 09AACCI5288D1ZG (Uttar Pradesh).
The CIN (Corporate Identification Number) of Iaso Pharmaceuticals is U24232DL2011PTC214139. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Iaso Pharmaceuticals has 1 court case on record: 1 filed against it.
Iaso Pharmaceuticals was incorporated on 15 February 2011, making it 15+ years old. It is registered with the Registrar of Companies, Delhi.
Keshav Chopra was appointed as Director on 15 Feb 2011. Narender Kumar Chopra was appointed as Managing Director on 15 Feb 2011.
Yes, Iaso Pharmaceuticals is registered as a small enterprise under Udyam registration (number: UDYAM-UP-28-0028373).
Iaso Pharmaceuticals can be reached through the website iasopharmaceuticals.com. Its registered office is in New Delhi, Delhi, India.

